Introduction
Healthcare bankers and investors evaluate MedTech companies through a specific set of KPIs that reflect the unique dynamics of the device business model. Unlike pharma KPIs (which focus on patent cliff exposure and pipeline probability of success), MedTech KPIs center on installed base economics, procedure volume trends, and the balance between growth investment and margin expansion.
Core KPIs by Category
Growth Metrics
| KPI | Benchmark | What It Signals |
|---|---|---|
| Organic revenue growth | 5-6% (industry avg) | Underlying business momentum |
| Procedure volume growth | 3-5% (most categories) | Market expansion rate |
| Market share trend | Stable or gaining | Competitive positioning |
| New product revenue % | 20-30% of total | Innovation pipeline health |
| Geographic mix shift | OUS growing faster | International expansion progress |
Installed Base and Utilization
For razor/blade companies, installed base metrics are as important as revenue metrics:
- Installed base units: Total systems placed at customer sites
- Utilization rate: Procedures per installed system per period (higher is better)
- Consumable attach rate: Revenue per procedure from consumables/instruments
- Service contract renewal rate: Typically 90%+ for healthy businesses
- Same-Store Utilization Growth
The increase in procedure volumes performed on systems that have been installed for more than one year. This metric isolates the organic growth of the existing installed base from the volume added by new system placements. Rising same-store utilization means surgeons are adopting the platform for additional procedure types, a strong signal of expanding clinical adoption. Declining same-store utilization could signal competitive displacement or market saturation.
Margin and Profitability
| Metric | Elite MedTech | Average MedTech | Interpretation |
|---|---|---|---|
| Gross margin | 65-72% | 55-62% | Product mix and pricing power |
| EBITDA margin | 30-38% | 20-28% | Operating leverage and efficiency |
| R&D % of revenue | 10-15% | 6-10% | Innovation investment intensity |
| FCF conversion | 80-95% of net income | 70-85% | Capital intensity and working capital |
The next article covers MedTech M&A, including the tuck-in acquisition strategy that drives deal volume in the sector.
